{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:18:21Z","timestamp":1769753901968,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beb\u00e9 Vida - Ci\u00eancias Para A Vida, S.A"},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UID\/BIM\/0493\/2020"],"award-info":[{"award-number":["UID\/BIM\/0493\/2020"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["2021.06521.BD"],"award-info":[{"award-number":["2021.06521.BD"]}]},{"DOI":"10.13039\/501100007157","name":"Instituto Polit\u00e9cnico do Porto","doi-asserted-by":"publisher","award":["IPP4COVID\/BI\/02\/2020"],"award-info":[{"award-number":["IPP4COVID\/BI\/02\/2020"]}],"id":[{"id":"10.13039\/501100007157","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Porto Research, Technology & Innovation Center","award":["PORTIC\/LabMi\/BI\/2021\/03"],"award-info":[{"award-number":["PORTIC\/LabMi\/BI\/2021\/03"]}]},{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prostate cancer (PCa) is the second most common malignancy in men, and the fifth leading cause of death worldwide. Mesenchymal stromal\/stem cells (MSC) have been identified in PCa, although contradictory effects in malignant transformation and tumor progression have been described. Since umbilical cord (UC) MSC and cord blood serum (CBS) are rich in numerous growth and anti-inflammatory factors, UC-MSC secretome and CBS are able to modulate tumor cell proliferation and survival as well as immunity and angiogenesis. In the present study, we address this relationship and investigate the influence of UC-MSC secretome and CBS on two human PCa cell lines (PC3 and LNCaP) and a normal epithelial prostate cell line (HPEpiC). Our results disclosed that upon exposure to UC-MSC-conditioned medium or CBS, both PC3 and LNCaP cells exhibited reduced viability, proliferation, and motility while non-malignant epithelial prostate cells were unaffected. These findings were corroborated by expression analysis of AKT\/PI3K signaling pathway, p53 and interleukin genes. UC-MSC and CBS factors decreased the expression of growth-stimulating AKT and PI3K effectors and simultaneously up-regulated the expression of tumor-suppressor p53. Moreover, a more anti-inflammatory expression profile was found in both malignant PCa cell lines. Altogether, these results shed light into possible mechanisms by which UC-MSC and CBS reduce PCa progression, further reinforcing their potential use as novel therapeutic agents in PCa.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s13577-023-00880-z","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T01:41:10Z","timestamp":1676943670000},"page":"1160-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of umbilical cord mesenchymal stromal\/stem cell secretome and cord blood serum in prostate cancer progression"],"prefix":"10.1007","volume":"36","author":[{"given":"Andr\u00e9","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Leite","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Ana Catarina","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Pilar","family":"Baylina","sequence":"additional","affiliation":[]},{"given":"Ruben","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-1773","authenticated-orcid":false,"given":"Andreia","family":"Gomes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,19]]},"reference":[{"key":"880_CR1","first-page":"107","volume":"10","author":"P Rawla","year":"2016","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol Elmer Press. 2016;10:107\u201325.","journal-title":"World J Oncol Elmer Press"},{"issue":"4","key":"880_CR2","first-page":"397","volume":"82","author":"VJ Sharp","year":"2010","unstructured":"Sharp VJ, Takacs EB, Powell CR. Prostatitis: diagnosis and treatment. Am Fam Physician. 2010;82(4):397\u2013406.","journal-title":"Am Fam Physician"},{"issue":"4","key":"880_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000435797","volume":"27","author":"C Bachmann","year":"2015","unstructured":"Bachmann C. Serenoa repens for benign prostatic hyperplasia. Schweiz Z f\u00fcr Ganzheitsmed\/Swiss J Integr Med. 2015;27(4):202\u20136.","journal-title":"Schweiz Z f\u00fcr Ganzheitsmed\/Swiss J Integr Med"},{"key":"880_CR4","unstructured":"Bott SN, KL, Prostate Cancer, E.P. Australia, Editor. 2015."},{"issue":"3","key":"880_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.suc.2020.01.002","volume":"100","author":"MC Hulvat","year":"2020","unstructured":"Hulvat MC. Cancer incidence and trends. Surg Clin North Am. 2020;100(3):469\u201381.","journal-title":"Surg Clin North Am"},{"issue":"6","key":"880_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"880_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2022.102864","volume":"63","author":"M Rahimi Tesiye","year":"2022","unstructured":"Rahimi Tesiye M, Abrishami Kia Z, Rajabi-Maham H. Mesenchymal stem cells and prostate cancer: a concise review of therapeutic potentials and biological aspects. Stem Cell Res. 2022;63: 102864.","journal-title":"Stem Cell Res"},{"issue":"24","key":"880_CR8","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317(24):2532\u201342.","journal-title":"JAMA"},{"issue":"11","key":"880_CR9","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1080\/09553002.2017.1359429","volume":"93","author":"A Abbasian Ardakani","year":"2017","unstructured":"Abbasian Ardakani A, Rajaee J, Khoei S. Diagnosis of human prostate carcinoma cancer stem cells enriched from DU145 cell lines changes with microscopic texture analysis in radiation and hyperthermia treatment using run-length matrix. Int J Radiat Biol. 2017;93(11):1248\u201356.","journal-title":"Int J Radiat Biol"},{"issue":"9","key":"880_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00535-019-01599-1","volume":"54","author":"J Driscoll","year":"2019","unstructured":"Driscoll J, Patel T. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease. J Gastroenterol. 2019;54(9):763\u201373.","journal-title":"J Gastroenterol"},{"issue":"1","key":"880_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.retram.2019.09.001","volume":"68","author":"LL Liau","year":"2020","unstructured":"Liau LL, et al. Characteristics and clinical applications of Wharton\u2019s jelly-derived mesenchymal stromal cells. Curr Res Transl Med. 2020;68(1):5\u201316.","journal-title":"Curr Res Transl Med"},{"issue":"6","key":"880_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127992","volume":"10","author":"A Subramanian","year":"2015","unstructured":"Subramanian A, et al. Comparative characterization of cells from the various compartments of the human umbilical cord shows that the Wharton\u2019s jelly compartment provides the best source of clinically utilizable mesenchymal stem cells. PLoS ONE. 2015;10(6): e0127992.","journal-title":"PLoS ONE"},{"issue":"3","key":"880_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00441-021-03461-4","volume":"385","author":"A Gomes","year":"2021","unstructured":"Gomes A, et al. Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach. Cell Tissue Res. 2021;385(3):497\u2013518.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"880_CR14","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1002\/jcp.27326","volume":"234","author":"S Shojaei","year":"2019","unstructured":"Shojaei S, et al. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: tumor progression versus tumor suppression. J Cell Physiol. 2019;234(4):3394\u2013409.","journal-title":"J Cell Physiol"},{"key":"880_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.652970","volume":"9","author":"M Sandon\u00e0","year":"2021","unstructured":"Sandon\u00e0 M, et al. Mesenchymal stromal cells and their secretome: new therapeutic perspectives for skeletal muscle regeneration. Front Bioeng Biotechnol. 2021;9: 652970.","journal-title":"Front Bioeng Biotechnol"},{"issue":"6","key":"880_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ymthe.2006.05.016","volume":"14","author":"N Noiseux","year":"2006","unstructured":"Noiseux N, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006;14(6):840\u201350.","journal-title":"Mol Ther"},{"issue":"5","key":"880_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076\u201384.","journal-title":"J Cell Biochem"},{"key":"880_CR18","doi-asserted-by":"publisher","DOI":"10.5772\/57460","author":"RWY Yeo","year":"2013","unstructured":"Yeo RWY, et al. Exosome: a novel and safer therapeutic refinement of mesenchymal stem cell. J Circulating Biomark. 2013. https:\/\/doi.org\/10.5772\/57460.","journal-title":"J Circulating Biomark"},{"issue":"1","key":"880_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13287-021-02697-9","volume":"13","author":"D Bian","year":"2022","unstructured":"Bian D, et al. The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review. Stem Cell Res Ther. 2022;13(1):24.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"880_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/157488810791268564","volume":"5","author":"AJ Salgado","year":"2010","unstructured":"Salgado AJ, et al. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther. 2010;5(2):103\u201310.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"8","key":"880_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.5966\/sctm.2015-0298","volume":"5","author":"CB Liu","year":"2016","unstructured":"Liu CB, et al. Human umbilical cord-derived mesenchymal stromal cells improve left ventricular function, perfusion, and remodeling in a porcine model of chronic myocardial ischemia. Stem Cells Transl Med. 2016;5(8):1004\u201313.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"880_CR22","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2337\/db11-1141","volume":"61","author":"Y Si","year":"2012","unstructured":"Si Y, et al. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes. 2012;61(6):1616\u201325.","journal-title":"Diabetes"},{"key":"880_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fncel.2019.00204","volume":"13","author":"B Soria","year":"2019","unstructured":"Soria B, et al. Human mesenchymal stem cells prevent neurological complications of radiotherapy. Front Cell Neurosci. 2019;13:204.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"880_CR24","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1038\/s41598-019-42964-7","volume":"9","author":"JY Song","year":"2019","unstructured":"Song JY, et al. Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses. Sci Rep. 2019;9(1):6623.","journal-title":"Sci Rep"},{"issue":"18","key":"880_CR25","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.3390\/ijms20184597","volume":"20","author":"S Eleuteri","year":"2019","unstructured":"Eleuteri S, Fierabracci A. Insights into the secretome of mesenchymal stem cells and its potential applications. Int J Mol Sci. 2019;20(18):4597.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"880_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15283\/ijsc.2009.2.1.59","volume":"2","author":"CW Park","year":"2009","unstructured":"Park CW, et al. Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells. 2009;2(1):59\u201368.","journal-title":"Int J Stem Cells"},{"issue":"4","key":"880_CR27","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/jcp.27011","volume":"234","author":"LN Zhang","year":"2019","unstructured":"Zhang LN, et al. Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells. J Cell Physiol. 2019;234(4):3570\u201382.","journal-title":"J Cell Physiol"},{"issue":"2","key":"880_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/cancers11020185","volume":"11","author":"C Melzer","year":"2019","unstructured":"Melzer C, von der Ohe J, Hass R. In vivo cell fusion between mesenchymal stroma\/stem-like cells and breast cancer cells. Cancers. 2019;11(2):185.","journal-title":"Cancers"},{"key":"880_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00043","author":"A Hmadcha","year":"2020","unstructured":"Hmadcha A, et al. Therapeutic potential of mesenchymal stem cells for cancer therapy. Front Bioeng Biotechnol. 2020. https:\/\/doi.org\/10.3389\/fbioe.2020.00043.","journal-title":"Front Bioeng Biotechnol"},{"key":"880_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108625","volume":"112","author":"L Lu","year":"2019","unstructured":"Lu L, et al. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K\/AKT signaling pathway. Biomed Pharmacother. 2019;112: 108625.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"880_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/stem.1247","volume":"31","author":"IA Ho","year":"2013","unstructured":"Ho IA, et al. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells. 2013;31(1):146\u201355.","journal-title":"Stem Cells"},{"issue":"22","key":"880_CR32","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","volume":"126","author":"C Lee","year":"2012","unstructured":"Lee C, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012;126(22):2601\u201311.","journal-title":"Circulation"},{"issue":"5","key":"880_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","volume":"40","author":"K Pakravan","year":"2017","unstructured":"Pakravan K, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1\u03b1\/VEGF signaling axis in breast cancer cells. Cell Oncol (Dordr). 2017;40(5):457\u201370.","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"880_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/pai.12023","volume":"24","author":"ME Belderbos","year":"2013","unstructured":"Belderbos ME, et al. Plasma-mediated immune suppression: a neonatal perspective. Pediatr Allergy Immunol. 2013;24(2):102\u201313.","journal-title":"Pediatr Allergy Immunol"},{"key":"880_CR35","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fimmu.2018.01282","volume":"9","author":"ST Cox","year":"2018","unstructured":"Cox ST, et al. Functional characterisation and analysis of the soluble NKG2D ligand repertoire detected in umbilical cord blood plasma. Front Immunol. 2018;9:1282.","journal-title":"Front Immunol"},{"key":"880_CR36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3389\/fimmu.2020.00942","volume":"11","author":"D Samarkanova","year":"2020","unstructured":"Samarkanova D, et al. Cord blood platelet rich plasma derivatives for clinical applications in non-transfusion medicine. Front Immunol. 2020;11:942.","journal-title":"Front Immunol"},{"issue":"3","key":"880_CR37","first-page":"405","volume":"11","author":"P Solves","year":"2013","unstructured":"Solves P, et al. Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study. Blood Transfus. 2013;11(3):405\u201311.","journal-title":"Blood Transfus"},{"issue":"1","key":"880_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, et al. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020;5(1):99.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"880_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbcan.2018.09.001","volume":"1870","author":"S Park","year":"2018","unstructured":"Park S, et al. PI3K pathway in prostate cancer: all resistant roads lead to PI3K. Biochim Biophys Acta Rev Cancer. 2018;1870(2):198\u2013206.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"880_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.smim.2017.12.003","volume":"35","author":"TL Whiteside","year":"2018","unstructured":"Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol. 2018;35:69\u201379.","journal-title":"Semin Immunol"},{"issue":"8","key":"880_CR41","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/cancers12082107","volume":"12","author":"R Hass","year":"2020","unstructured":"Hass R. Role of MSC in the tumor microenvironment. Cancers. 2020;12(8):2107.","journal-title":"Cancers"},{"issue":"11","key":"880_CR42","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jog.13432","volume":"43","author":"FA Dabrowski","year":"2017","unstructured":"Dabrowski FA, et al. Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue. J Obstet Gynaecol Res. 2017;43(11):1758\u201368.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"880_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13287-017-0668-1","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun X, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther. 2017;8(1):241.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"880_CR44","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1096\/fj.201800131RR","volume":"33","author":"J Yao","year":"2019","unstructured":"Yao J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. Faseb j. 2019;33(2):1695\u2013710.","journal-title":"Faseb j"},{"issue":"4","key":"880_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/ICO.0b013e3182580762","volume":"32","author":"P Versura","year":"2013","unstructured":"Versura P, et al. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea. 2013;32(4):412\u20138.","journal-title":"Cornea"},{"issue":"4","key":"880_CR46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12253-016-0066-5","volume":"22","author":"I Riquelme","year":"2016","unstructured":"Riquelme I, et al. The gene expression status of the PI3K\/AKT\/mTOR pathway in gastric cancer tissues and cell lines. Pathol Oncol Res. 2016;22(4):797\u2013805.","journal-title":"Pathol Oncol Res"},{"key":"880_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1755-8794-5-34","volume":"5","author":"J Zhou","year":"2012","unstructured":"Zhou J, et al. Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library. BMC Med Genom. 2012;5:34. https:\/\/doi.org\/10.1186\/1755-8794-5-34.","journal-title":"BMC Med Genom"},{"issue":"3","key":"880_CR48","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/bcr2594","volume":"12","author":"CJ Creighton","year":"2010","unstructured":"Creighton CJ, et al. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer. Breast Cancer Res. 2010;12(3):R40.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"880_CR49","doi-asserted-by":"publisher","first-page":"E337","DOI":"10.1152\/ajpendo.00718.2006","volume":"293","author":"MR Dasu","year":"2007","unstructured":"Dasu MR, Devaraj S, Jialal I. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab. 2007;293(1):E337\u201346.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"880_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00109-011-0809-4","volume":"90","author":"MF Chen","year":"2012","unstructured":"Chen MF, et al. Role of interleukin 1 beta in esophageal squamous cell carcinoma. J Mol Med (Berl). 2012;90(1):89\u2013100.","journal-title":"J Mol Med (Berl)"},{"issue":"2a","key":"880_CR51","first-page":"709","volume":"25","author":"H Kai","year":"2005","unstructured":"Kai H, et al. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res. 2005;25(2a):709\u201313.","journal-title":"Anticancer Res"},{"issue":"11","key":"880_CR52","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/sj.bjc.6603446","volume":"95","author":"DA Deans","year":"2006","unstructured":"Deans DA, et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer. Br J Cancer. 2006;95(11):1568\u201375.","journal-title":"Br J Cancer"},{"issue":"2","key":"880_CR53","first-page":"595","volume":"42","author":"L Chen","year":"2019","unstructured":"Chen L, et al. IL-10 secreted by cancer-associated macrophages regulates proliferation and invasion in gastric cancer cells via c-Met\/STAT3 signaling. Oncol Rep. 2019;42(2):595\u2013604.","journal-title":"Oncol Rep"},{"issue":"9","key":"880_CR54","first-page":"2899","volume":"31","author":"XP Jiang","year":"2011","unstructured":"Jiang XP, et al. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells. Anticancer Res. 2011;31(9):2899\u2013906.","journal-title":"Anticancer Res"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-023-00880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-023-00880-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-023-00880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T15:41:40Z","timestamp":1681746100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-023-00880-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,19]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1007\/s13577-023-00880-z","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,19]]},"assertion":[{"value":"20 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author AG is an employee of \u201cBeb\u00e9 Vida\u2014Ci\u00eancias Para A Vida, S.A\u201d, a Portuguese cord blood banking company. Figure\u00a0for graphical abstract was created with BioRender software, \u00a9biorender.com.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The informed consent for the use of umbilical cord samples for research was obtained in accordance with the requirements of the local law at the time of collection.CB and UC units were collected by qualified health care professionals in authorized maternity hospitals. Before delivery, mothers signed an informed consent donating these samples for both research and validation purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}